Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Glucagon is a recognised therapy for the disorder ... 2019 as a hypoglycaemia rescue therapy for diabetics. Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication.

Wearable Furosemide Delivery System Approved for CKD Patients Baqsimi (glucagon nasal powder) Antihypoglycemic Treatment of severe hypoglycemia in patients aged 1 year and older with diabetes. Baqsimi ...

Alternative dosing routes, such as rectal and intranasal (IN) routes, have been suggested as options for oral or intravenous administration. Rhinitis and pharmacological agents used for treatment ...